271 related articles for article (PubMed ID: 21069339)
1. The uptake of paclitaxel and docetaxel into ex vivo porcine bladder tissue from polymeric micelle formulations.
Tsallas A; Jackson J; Burt H
Cancer Chemother Pharmacol; 2011 Aug; 68(2):431-44. PubMed ID: 21069339
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of stabilized double loaded mPEG-PDLLA micelles for simultaneous delivery of paclitaxel and docetaxel.
Ouahab A; Shao C; Shen Y; Tu J
Drug Dev Ind Pharm; 2014 Jul; 40(7):860-8. PubMed ID: 23600653
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.
Mugabe C; Matsui Y; So AI; Gleave ME; Baker JH; Minchinton AI; Manisali I; Liggins R; Brooks DE; Burt HM
Clin Cancer Res; 2011 May; 17(9):2788-98. PubMed ID: 21357680
[TBL] [Abstract][Full Text] [Related]
4. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
Letchford K; Liggins R; Wasan KM; Burt H
Eur J Pharm Biopharm; 2009 Feb; 71(2):196-206. PubMed ID: 18762253
[TBL] [Abstract][Full Text] [Related]
5. Arginine-stabilized mPEG-PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery.
Shi J; Zhang J; Shen Y; Tang L; Zhao J; Tu J; Tian Y; Feng Y
Drug Deliv; 2015 Feb; 22(2):168-81. PubMed ID: 24215124
[TBL] [Abstract][Full Text] [Related]
6. Enhanced taxane uptake into bladder tissues following co-administration with either mitomycin C, doxorubicin or gemcitabine: association to exfoliation processes.
Pandey R; Jackson JK; Liggins R; Mugabe C; Burt HM
BJU Int; 2018 Nov; 122(5):898-908. PubMed ID: 29862643
[TBL] [Abstract][Full Text] [Related]
7. Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium.
Mugabe C; Raven PA; Fazli L; Baker JH; Jackson JK; Liggins RT; So AI; Gleave ME; Minchinton AI; Brooks DE; Burt HM
Biomaterials; 2012 Jan; 33(2):692-703. PubMed ID: 22014457
[TBL] [Abstract][Full Text] [Related]
8. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
[TBL] [Abstract][Full Text] [Related]
9. Tissue Permeability Effects Associated with the Use of Mucoadhesive Cationic Nanoformulations of Docetaxel in the Bladder.
Pandey R; Jackson JK; Mugabe C; Liggins R; Burt HM
Pharm Res; 2016 Aug; 33(8):1850-61. PubMed ID: 27091034
[TBL] [Abstract][Full Text] [Related]
10. Copolymer micelles and nanospheres with different in vitro stability demonstrate similar paclitaxel pharmacokinetics.
Letchford K; Burt HM
Mol Pharm; 2012 Feb; 9(2):248-60. PubMed ID: 22204437
[TBL] [Abstract][Full Text] [Related]
11. Development and in vitro characterization of paclitaxel and docetaxel loaded into hydrophobically derivatized hyperbranched polyglycerols.
Mugabe C; Liggins RT; Guan D; Manisali I; Chafeeva I; Brooks DE; Heller M; Jackson JK; Burt HM
Int J Pharm; 2011 Feb; 404(1-2):238-49. PubMed ID: 21093563
[TBL] [Abstract][Full Text] [Related]
12. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
Ostacolo L; Marra M; Ungaro F; Zappavigna S; Maglio G; Quaglia F; Abbruzzese A; Caraglia M
J Control Release; 2010 Dec; 148(2):255-63. PubMed ID: 20816710
[TBL] [Abstract][Full Text] [Related]
13. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
[TBL] [Abstract][Full Text] [Related]
14. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
[TBL] [Abstract][Full Text] [Related]
15. Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity.
Wang F; Shen Y; Xu X; Lv L; Li Y; Liu J; Li M; Guo A; Guo S; Jin F
Int J Pharm; 2013 Nov; 456(1):101-12. PubMed ID: 23968782
[TBL] [Abstract][Full Text] [Related]
16. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
17. Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel.
Zhang X; Wu Y; Zhang M; Mao J; Wu Y; Zhang Y; Yao J; Xu C; Guo W; Yu B
Int J Nanomedicine; 2017; 12():8779-8799. PubMed ID: 29263668
[TBL] [Abstract][Full Text] [Related]
18. Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment.
Knemeyer I; Wientjes MG; Au JL
Cancer Chemother Pharmacol; 1999; 44(3):241-8. PubMed ID: 10453726
[TBL] [Abstract][Full Text] [Related]
19. Polysorbate 80 coated poly (ɛ-caprolactone)-poly (ethylene glycol)-poly (ɛ-caprolactone) micelles for paclitaxel delivery.
Wang Y; Wang C; Gong C; Wang Y; Guo G; Luo F; Qian Z
Int J Pharm; 2012 Sep; 434(1-2):1-8. PubMed ID: 22609127
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy.
Lu Z; Yeh TK; Tsai M; Au JL; Wientjes MG
Clin Cancer Res; 2004 Nov; 10(22):7677-84. PubMed ID: 15570001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
